Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage.
Thirty-seven patients with intractable bladder hemorrhage were treated with intravesical epsilon aminocaproic acid (EACA). Radiation cystitis and cyclophosphamide-induced cystitis were the two most common causes of intractable bladder hemorrhage. Thirty-four patients responded to treatment. No side effects were noted. Intravesical EACA appears to be a safe and effective method to control intractable bladder hemorrhage.
Singh
I
I
Department of Urology, State University of New York, Brooklyn.
Laungani
G B
GB
D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D015119:Aminocaproic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D007507:Therapeutic Irrigation; D001745:Urinary Bladder Diseases / Q000188:drug therapy* / Q000209:etiology
D015119:Aminocaproic Acid